epocrates

Review of Epocrates new Electronic Health Record, iMedicalApps exclusive

Thumbnail image for Review of Epocrates new Electronic Health Record, iMedicalApps exclusive

We share the details of our tour through Epocrates EHR, the latest addition to a crowded field. We were impressed and look forward to seeing the additions to come.

First Aid Q&A iPhone app for USMLE Step 1 is a great resource, but not for everyone

Thumbnail image for First Aid Q&A iPhone app for USMLE Step 1 is a great resource, but not for everyone

Part of the popular First Aid series, this app is a great resource for medical students preparing for Step 1. However, certain deficits mean it is not for everyone.

Free Epocrates Essentials App for Med Students

Thumbnail image for Free Epocrates Essentials App for Med Students

While there are very few things in life that are free, the developers of the popular Epocrates line of apps beg to differ.  For the first two weeks of August, Epocrates Essentials will be available to download FREE to all medical students who attend an accredited school. This is quite a good deal, as the original value of the app is $159.00.

Epocrates electronic health record raises new possibilities and ethical questions

Thumbnail image for Epocrates electronic health record raises new possibilities and ethical questions

Last week, Epocrates announced the availability of its long-anticipated EHR platform cleverly named Epocrates EHR — but does Epocrates close relationship with pharma complicate the picture?

Pharma influence in popular physician medical apps goes mainstream with New York Times

Thumbnail image for Pharma influence in popular physician medical apps goes mainstream with New York Times

Covered by iMA nearly a month ago, the New York Times takes the issue of pharma influence in mobile apps mainstream.

Physicians, Pharma, and “free” medical apps

Thumbnail image for Physicians, Pharma, and “free” medical apps

The medical app industry is a big business, but the apps are no longer the product – the physicians, nurses, and other healthcare providers who use them are. In the first part of this series, we examined some of the financial forces driving the medical app industry. Our focus then was Epocrates, the veritable founder of the industry. As is clearly stated in their recent SEC statement, Epocrates primary revenue stream has become the pharmaceutical industry and as such a [Read more]

Why “free” Epocrates and Medscape aren’t really free medical apps for Physicians

Thumbnail image for Why “free” Epocrates and Medscape aren’t really free medical apps for Physicians

Medical apps are a big business, but not because of the apps. In this two-part series, we look at how the physicians who use these apps became the product.

Pill Identifier Lite : Head-to-Head comparison against pill identifiers in Epocrates and Lexi-Comp

Thumbnail image for Pill Identifier Lite :  Head-to-Head comparison against pill identifiers in Epocrates and Lexi-Comp

Pill Identification can represent a challenging but occasionally even life-saving endeavor for healthcare professionals, examples include: an ER physician diagnosing beta-blockade toxicity in a bradycardic patient or oral hypoglycemic toxicity in a seizing patient or parents discovering an unknown stray pill in their teenager’s belongings. Read how Pill Identifier Lite stacks up against similar free offerings from Epocrates and Lexi Comp.

Epocrates is now valued at half a billion dollars – but is it worth it?

Thumbnail image for Epocrates is now valued at half a billion dollars – but is it worth it?

Epocrates is one of the hottest IPO’s of this year. Not everyone thinks it should be.

Epocrates IPO blows away analysts expectation – a great sign for mHealth entrepreneurs

Thumbnail image for Epocrates IPO blows away analysts expectation – a great sign for mHealth entrepreneurs

When Epocrates first opened up shop in 1998, it was entering what, at the time, seemed to be a niche market – providing medical reference tools on PDA’s. Turns out, what they were really doing was catching the leading edge of a transformation in medical information technology, largely powered by developments in the consumer telecommunications industry. And they have now ridden that wave into a wildly successful IPO yesterday. And in the setting of an otherwise relatively anemic market and [Read more]

Analysis of Free Drug Medical Reference Apps: Epocrates, Lexi-Comp, Medscape, Micromedex, Pepid, Skyscape

Thumbnail image for Analysis of Free Drug Medical Reference Apps: Epocrates, Lexi-Comp, Medscape, Micromedex, Pepid, Skyscape

In this comprehensive review, iMedicalApps compares the free versions of the six of the best-known medical reference apps for the iPhone/iPod touch/iPad: Epocrates, Lexi-Comp, MedScape, Micromedex, Pepid, and Skyscape.

Epocrates acquisition of Modality makes sense while Android users could be left out in the cold

Thumbnail image for Epocrates acquisition of Modality makes sense while Android users could be left out in the cold

Epocrates acquisition of Modality makes sense. However, Android users could be left out in the cold based on the track record of both companies.